Target-to-blood ratios of 125I-BC8-FP activity measured at 24 and 48 hours after infusion
| . | BC8-FP . | 24 h . | 48 h . |
|---|---|---|---|
| Experiment 2 | LN:blood ratio | 1:1 | 1.5:1 |
| Experiment 3 | LN:blood ratio | 0.8:1 | 1.3:1 |
| Experiment 5 | LN:blood ratio | 0.83:1 | 2:1 |
| . | BC8-FP . | 24 h . | 48 h . |
|---|---|---|---|
| Experiment 2 | LN:blood ratio | 1:1 | 1.5:1 |
| Experiment 3 | LN:blood ratio | 0.8:1 | 1.3:1 |
| Experiment 5 | LN:blood ratio | 0.83:1 | 2:1 |
Lymph node (LN) and blood samples were collected at serial time points, and specimen activity was measured in a dual-channel gamma counter. Calculated ratios of measured activity were superior at 48 versus 24 hours after 125I-BC8-FP infusion.